Zhixiang Pharma

Bioworkshops, also known as Zhixiang Pharma, is a specialized biologics Contract Development and Manufacturing Organization (CDMO) based in Suzhou, China. Established in 2018, the company offers comprehensive services for the development and manufacture of therapeutic proteins, including monoclonal antibodies, bispecifics, and fusion proteins. Their capabilities span from early-stage cell line development and process characterization to commercial-scale GMP production using advanced single-use technology. Bioworkshops operates state-of-the-art facilities equipped with multiple 2,000L bioreactors, catering to both domestic and international biopharmaceutical clients. The company aims to accelerate the path from drug discovery to clinical trials and market entry for global partners. With a leadership team drawn from top-tier global pharmaceutical firms, Bioworkshops focuses on delivering high-quality, cost-effective manufacturing solutions.